At the rate of "growth" of this stock, you may want to keep your two cents, HA!
They burn thru 20M last quarter to keep operations running, going on their own after Sanofi drops out of the partnership won't long with just a one-time infusing of cash from the Israeli market. They are required to keep 25M on the books due to their obligation to Deerfield. You're just holding a bag that is opening at the seams.
haha, longs are happy, yeah right. The only one smiling are the shorters. How many of the old longs, and I mean OLD bought when it was in the 1's. All of you who actually bought AND held have losses on a massive scale. Lose 60-90% value, who would be happy? I doubt your, EBT can't buy more shares of MNKD since your personal finances are probably in shambles reflected if you still think this is a good stock.
hahaha, didn't you say the same thing at $8? at $5? at $3? hey maybe you'll get to say it at under $1 too
if HE said it's a BUY then it's time to SELL. Cramer is the biggest clown, who by the way, employs Adram F. at his site.
Oooh, big internet tough guy. Try moving out of your mom's basement and stop living in a fantasy world.
Oh how typical of the low IQ, cannot even retort with any facts, figures to back your front so you need to use ad hominem attacks. I used to believe the hype buying at the 4s and 6s, but started to see through the ridiculous lies the pumpers kept posting when it did not match the filings that were coming out. I told everyone to sell at $10 like I did after the approval, have fun still holding that bag. I like to come back and needle the pumpers with their useless drivels since they still keep at it despite the apparent downward slide.
OMG, so you are bragging that you bought between $13-18 a share? How's that working for ya, even a basic money market fund MADE more money than you.
Yet again MNKD drops when others are going up. Heck even KERX is up over 3% when MNKD is down 3% yet you still got cheerleaders pumping in the face of reality of the situation. You are better off investing in leveraged oil & NG at this point than dreaming of a surge in MNKD which is now back to where it was Feb '09 and that was prior to the approval. All you got now is the possibility of increase in scripts since no one is going to pay a premium on a buyout on a drug that is losing money. If there was such potential then the pps would reflect that but that has passed a year ago.
Won't be cheap? He doesn't have much leverage to bargain with. Here comes the clue train! Next stop is YOU! PPS has dropped to around 20% of its value when it was approved last year. Disappointing sales, no filings mentioned for other markets, no mention of additional commitment from SNY. Al has sunk alot of money into this and has no flowery revenue reports to show for it. He has very little to support a high price aside from his pride & greed which doesn't work well at the negotiation table if he has nothing else to back it up. SNY or any BP doesn't give money away to be nice guys, if the drug doesn't produce profit, they aren't interested. You see the leverage is on SNY's side if they even are interested in a buy out, but what supports that theory besides maybe hemorrhaging more money for a tax write off? HA! He either sells at a loss to recoup some of the money back or ride it down all the way.
So IF was so easy for approval then why haven't they filed in any of the EU nations since FDA approval? Yeah that's what I thought
1-There is no EU agency, you have to apply to each nation to be approved to market & sell your drugs there so you comment on "EU approval" is baseless. The EMA gives recommendations but is not a regulatory body.
2-The EU nations have stricter guidelines than the FDA, they don't get involved in the entire trial phases like the FDA but they are much more regulated as a society. Heck you can't sell GMO produce there, the US even with its more relaxed standards slapped Afrezza with a black label, think the EU member nations are going to go easy on them?
3-The EU has about comparable diabetic population in the US, 33M to 29M. So let's see, if it has failed to be this "blockbuster" for over year since approval to take off here, why would it do better in region with stricter standards?
You're better off investing in oil & NG while the market is depressed, that is a given it will go up within the next year. What has MNKD done in the past 7 years?
...and it is around 1/3 of the pps since then. Discuss.
You have no basis, none, to back that up. Highest it has been in the past 3 years was around $18 and has only steadily dropped. If there was any chance for an approved drug to shoot up, it was in the first year of its debut on the drug market but the demand never materialized so hence the decline. If there was a chance for this being a good profit maker (not even a blockbuster) then it would have already happened.
Reading all these pumpers pathetic attempts to reason how it is the shorts or analysts with an agenda for the reason why the stock keeps is not gaining any traction. They refuse to address the reason why the stock keeps going lower and lower is because the drug is not selling. Sounds very shrill and empty as these are teh same reasons repeated over and over for the past few years. Very few blockbuster drugs come back as a surprise and boost a company's earnings this far out from launch. The public & doctors don't care for the extra hoops the black label requires for patients go through for the prescription. If it wasn't for that then the results would be different.
You think the silly pumpers would have run out of good things to say since it just keeps tanking. I understand the game before approval, but its been one year and it is about 1/3 of the stock price since the peak then. Though I got out at $10 I did not think it would drop so low again, I've thought of getting back in but I do not see any spectacular growth potential that I once did, hell if it had that it would have already taken off then if you believed all the cheerleaders like I once did, I've moved most of my money into leveraged oil bull ETF for now.